-
公开(公告)号：KR101742266B1
公开(公告)日：2017-06-01
申请号：KR1020100052481
申请日：2010-06-03
Applicant: (주)아모레퍼시픽
IPC: A61K36/9066 , A61K36/28 , A61K31/702 , A23L1/30
Abstract: 본발명은숙취개선용조성물에관한것으로, 보다상세하게는울금추출물, 밀크씨슬추출물및 키토올리고당을유효성분으로함유하는위, 간기능및 숙취개선용조성물에관한것이다. 또한본 발명에의한조성물은바람직하게는창출, 산사, 맥아및 작약을포함하는식물성분혼합농축액; 인진, 백출및 구기자를포함하는식물추출혼합농축액; 및홍삼농축액중 1종이상을더 포함한다.
-
公开(公告)号：KR101707494B1
公开(公告)日：2017-02-16
申请号：KR1020160027525
申请日：2016-03-08
Applicant: (주)아모레퍼시픽
IPC: A23L27/00 , A23L1/0522 , A23L1/30
Abstract: 본발명은난소화성말토덱스트린을함유하는쓴맛억제제및 이쓴맛억제제를포함하는인삼조성물을제공한다. 본발명에의하면, 인삼의지표성분의손실없이특유의쓴맛이차폐되어용이한섭취를가능하게하는효과가있다.
Abstract translation: 本发明提供含有难消化的麦芽糖糊精的苦味抑制剂和包含苦味抑制剂的人参组合物。 根据本发明，可以消除人参的特殊苦味，而不会损失人参中的标记成分，从而能够容易地摄入人参。
-
公开(公告)号：KR1020160102368A
公开(公告)日：2016-08-30
申请号：KR1020160104371
申请日：2016-08-17
Applicant: (주)아모레퍼시픽
IPC: A61K36/258 , A61K31/70 , A61K31/704
CPC classification number: A61K36/258 , A61K31/70 , A61K31/704
Abstract: 본발명에따른조성물은, 사포닌을함유하는인삼(Panax ginseng C.A. Meyer) 열매의추출물을유효성분으로포함하는암 치료또는예방용조성물로서, 상기인삼열매추출물을유효성분으로함유하는조성물은종래알려진인삼근추출물을유효성분으로포함한조성물과다른조성을나타내며, 우수한항암효능을발휘할수 있음을확인하였는바, 암의치료또는예방에매우적합하다.
Abstract translation: 根据本发明的组合物是包含含皂苷的人参C.A.Meyer果实提取物作为治疗或预防癌症的有效成分的组合物。 与人参作为有效成分的常规已知组合物相比，包含人参C.A.Meyer果实提取物作为有效成分的组合物显示出不同的组成，并且可以显示出优异的抗癌功效，从而基本上适合于治疗或预防癌症。
-
74.发明公开
公开(公告)号：KR1020140122533A
公开(公告)日：2014-10-20
申请号：KR1020130039328
申请日：2013-04-10
Applicant: (주)아모레퍼시픽
Abstract: 본 발명은 황기 부정근의 대량생산방법에 관한 것으로서, (a)황기 종자를 멸균하여 무균화하는 단계; (b)상기 무균화된 황기 종자의 발아를 유도하는 단계; (c)발아된 황기로부터 식물호르몬을 사용하여 부정근을 유도하는 단계; (d)상기 유도된 부정근을 액체배양하는 단계;및 (e)상기 배양된 부정근을 엘리시터(Elicitor)로 처리하고 생물반응기(Bioreactor)에서 배양하는 단계를 포함함으로써 아스트라갈로사이드 IV(Astragaloside IV)의 함량을 현저히 증가시킨 황기 부정근을 대량으로 생산할 수 있다.
Abstract translation: 本发明涉及一种大规模生产黄芪不定根的方法。 该方法包括：（a）通过对黄芪的种子进行灭菌来除去微生物的步骤; （b）诱导灭菌的黄芪种子发芽的步骤; （c）使用植物激素从发芽的黄芪中诱导不定根的步骤; （d）液体培养诱导的不定根的步骤; 和（e）用激发剂处理培养的不定根并在生物反应器中孵育的步骤，从而能够大规模生产黄芪的黄芪甲苷IV不定根。
-
公开(公告)号：KR1020140069908A
公开(公告)日：2014-06-10
申请号：KR1020120137769
申请日：2012-11-30
Applicant: (주)아모레퍼시픽
IPC: A61K36/258 , A61P27/02
CPC classification number: A61K36/258 , A23L33/105 , A23V2002/00 , A23V2200/30 , A23V2250/2124 , Y10S514/912
Abstract: The present invention relates to a composition comprising a ginseng fruit extract as an active ingredient which provides overall health benefits of the eye by alleviating symptoms of eye fatigue, tightness, dryness, pain, and itching. The composition according to the present invention has an excellent effect of promoting eye health and can effectively alleviating fatigue of the eyes by comprising the extract of ginseng fruit.
Abstract translation: 本发明涉及包含人参果实提取物作为活性成分的组合物，其通过减轻眼睛疲劳，紧张，干燥，疼痛和瘙痒的症状来提供眼睛的整体健康益处。 根据本发明的组合物具有促进眼睛健康的优异效果，并且可以通过包含人参水果的提取物来有效地减轻眼睛的疲劳。
-
Patent Agency Ranking
公开(公告)号：KR101372037B1
公开(公告)日：2014-03-10
申请号：KR1020100031473
申请日：2010-04-06
Applicant: (주)아모레퍼시픽
IPC: A61K31/425 , A61K31/166 , A61P21/00
CPC classification number: A61K36/481 , A61K31/202 , A61K36/00 , A61K36/185 , A61K36/282 , A61K36/355 , A61K36/424 , A61K36/44 , A61K36/488 , A61K36/537 , A61K36/54 , A61K36/67 , A61K36/70 , A61K36/73 , A61K36/752 , A61K36/815 , A61K36/882 , A61K36/9064 , A61K45/06 , A61K2300/00
Abstract: 본 발명은 PPAR-δ 활성 촉진 물질, AMPK 활성 촉진 물질 및 PGC1-α 활성 촉진 물질을 유효 성분으로 포함하는 근육 타입 변화 촉진, 근육량 증가, 근육 강화, 운동 능력 향상, 지질 감소, 지질 축적 억제, 혈당 감소, 체중 조절 또는 체중 감소용 조성물을 제공한다.
-
公开(公告)号：KR1020130078387A
公开(公告)日：2013-07-10
申请号：KR1020110147304
申请日：2011-12-30
Applicant: (주)아모레퍼시픽
CPC classification number: A61K36/82
Abstract: PURPOSE: A composition containing a Camellia sinensis leaf extract, a Camellia sinensis flower extract, and a Camellia sinensis seed extract as active ingredients is provided to activate AMP-activated protein kinase (AMPK), to suppress fatty acid synthesis, and to promote fatty acid oxidation and glucose absorption, thereby preventing and treating metabolic syndrome. CONSTITUTION: A composition for preventing or treating metabolic syndrome contains a Camellia sinensis leaf extract, a Camellia sinensis flower extract, and a Camellia sinensis seed extract as active ingredients, in a weight ratio of 4-12:0.3-4:0.3-4. The composition contains the Camellia sinensis leaf extract and the Camellia sinensis flower and seed extracts in a weight ratio of 4-12:0.2-8. The metabolic syndrome is a glucoside metabolic syndrome or a lipid metabolic syndrome. The metabolic syndrome includes one or more among obesity, hyperlipidemia, type 2 diabetes, arteriosclerosis, myocardial infarction, and angina pectoris. The composition is a pharmaceutical composition. [Reference numerals] (AA) Mixture of Camellia sinensis leaf, flower, and seed extracts; (BB) Camellia sinensis flower extract; (CC) Camellia sinensis seed extract; (DD) Camellia sinensis leaf extract
Abstract translation: 目的：提供含有山茶叶提取物，山茶花提取物和山茶种子提取物作为活性成分的组合物，以激活AMP活化蛋白激酶（AMPK），抑制脂肪酸合成，促进脂肪酸 氧化和葡萄糖吸收，从而预防和治疗代谢综合征。 构成：用于预防或治疗代谢综合征的组合物含有山茶花提取物，山茶花提取物和山茶种子提取物作为活性成分，重量比为4-12:0.3-4:0.3-4。 该组合物含有山茶叶提取物和山茶花和种子提取物，重量比为4-12：0.2-8。 代谢综合征是葡萄糖苷代谢综合征或脂代谢综合征。 代谢综合征包括肥胖，高脂血症，2型糖尿病，动脉硬化，心肌梗塞和心绞痛中的一种或多种。 组合物是药物组合物。 （参考号）（AA）山茶叶，花和种子提取物的混合物; （BB）山茶花提取物; （CC）山茶籽提取物; （DD）山茶叶提取物
-
公开(公告)号：KR1020130047932A
公开(公告)日：2013-05-09
申请号：KR1020110112764
申请日：2011-11-01
Applicant: (주)아모레퍼시픽
Abstract: PURPOSE: A composition containing syringaresinol for suppressing aging is provided to enhance SIRT1 expression, to suppress MMP-9 expression and collagen decomposition, and to improve anti-wrinkling. CONSTITUTION: A composition for anti-aging contains 1-80wt% of syringaresinol as an active ingredient. Syringaresinol is contains in one or more extracts selected from a lindseed extract, a Phellodendri cortex extract, an Acanthopanacis cortex extract, a sesame extract, and a ginseng fruit extract. Syringaresinol is prepared using one or more selected from the group consisting of water, an organic solvent, and a mixture thereof. The composition promotes SIRT1(sirtuin 1) expression.
Abstract translation: 目的：提供含有用于抑制老化的丁香精醇的组合物，以增强SIRT1表达，抑制MMP-9的表达和胶原分解，并改善抗皱纹。 构成：抗老化组合物含有1-80重量％的作为活性成分的丁香麻醇。 吩噻嗪醇含有一种或多种提取物，其选自泻药提取物，黄柏提取物，刺五加皮质提取物，芝麻提取物和人参果实提取物。 使用一种或多种选自水，有机溶剂及其混合物的组合制备吸入辛胺醇。 该组合物促进SIRT1（sirtuin 1）表达。
-
公开(公告)号：KR1020130047792A
公开(公告)日：2013-05-09
申请号：KR1020110110484
申请日：2011-10-27
Applicant: (주)아모레퍼시픽
Abstract: PURPOSE: A composition containing syringaresinol as an active ingredient is provided to suppress melanogenesis and tyrosinase activity, and to ensure anti-oxidation and skin whitening. CONSTITUTION: A composition for skin whitening contains 0.001-20wt% of syringaresinol as an active ingredient. The composition enhances the brightness and uniformity of skin color. The composition treats hyperpigmentation. The hyperpigmentation includes melasma, seborrheic keratosis, freckle, nevus, and dark circle. Syringaresinol is contained in an extract selected among a lindseed extract, a Phellodendri cortex extract, an Acanthopanacis cortex extract, a sesame extract, and a ginseng fruit extract. The composition is used for removing dead skin cells and promotes dead skin cell turn over. [Reference numerals] (AA) Syringaresinol
Abstract translation: 目的：提供含有作为活性成分的丁香红醇的组合物，以抑制黑素生成和酪氨酸酶活性，并确保抗氧化和皮肤美白。 构成：用于皮肤美白的组合物含有0.001-20重量％的作为活性成分的丁二腈。 该组合物增强了肤色的亮度和均匀性。 该组合物治疗色素沉着过度。 色素沉着过多包括黑斑病，脂溢性角化病，雀斑，痣和黑眼圈。 戒毒素包含在选自泻药提取物，黄柏提取物，刺五加皮质提取物，芝麻提取物和人参果实提取物中的提取物中。 该组合物用于去除死皮细胞并促进死皮细胞翻转。 （标号）（AA）异丙肾上腺素
-
公开(公告)号：KR1020130046115A
公开(公告)日：2013-05-07
申请号：KR1020110110486
申请日：2011-10-27
Applicant: (주)아모레퍼시픽
CPC classification number: A61K31/34 , A23L33/105 , A23V2002/00 , A61K9/0014 , A61K9/0053 , A61K9/0095 , A61K9/1652 , A61K9/2059 , A61K36/00 , A61K36/185 , A61K36/254 , A61K36/258 , A61K36/55 , A61K36/756 , A23V2200/302 , A23V2200/326 , A23V2250/21
Abstract: PURPOSE: A composition containing syringaresinol for suppressing aging of blood vessels is provided to enhance SIRT 1 expression in vascular cells, to activate telomerase, and to suppress aging of blood vessel. CONSTITUTION: A composition for suppressing aging of blood vessel contains syringaresinol as an active ingredient. The composition is used for preventing or treating cardiovascular diseases such as cerebral infarction, cerebral hemorrhage, ischemic heart disease, myocardial infarction, and arteriosclerosis. Syringaresinol is contained in extracts selected among a linseed extract, a Phellodendri cortex extract, an Acanthopanax sessiliflorum extract, a sesame extract, and a ginseng fruit extract. [Reference numerals] (AA) Syringaresinol
Abstract translation: 目的：提供一种含有抑制血管老化的丁香ares酚的组合物，以增强血管细胞中SIRT 1的表达，激活端粒酶，抑制血管老化。 构成：用于抑制血管衰老的组合物含有作为活性成分的丁香腈。 该组合物用于预防或治疗心脑血管疾病如脑梗塞，脑出血，缺血性心脏病，心肌梗死和动脉硬化。 提取物中含有亚麻子提取物，黄柏提取物，刺五加提取物，芝麻提取物和人参果实提取物中的提取物。 （标号）（AA）异丙肾上腺素
-
-
-
-
-
-
-
-
-
Search Results
146
records
(took 0.026 seconds)
